Joint Venture

A Quebec partnership has completed the first building with carbon-negative, insulated blocks, a breakthrough aiming to decarbonize construction from the ground up.

A partnership between Kinko Optical and Beneq aims to scale AR waveguide production, tackling a key obstacle for the next generation of XR devices.

A new partnership will supply Japan's surging cell therapy sector with critical, GMP-grade materials, aiming to accelerate the path from lab to clinic.

The Collegiate Cup is set as 12 universities head to Florida for the national championship, showcasing future stars and the rapid growth of cricket in America.

A new partnership between WELL Health and HEALWELL AI uses artificial intelligence to find trial participants, but puts patient consent at the forefront.

A veteran-led firm, backed by Kevin O'Leary, brings its unique evacuation system to Oklahoma, setting a new, proactive standard for school security.

A new partnership promises to transform internal emails from simple memos into data-rich, engaging employee experiences that drive measurable impact.

Nicox's novel glaucoma drug NCX 470 receives positive FDA feedback, keeping its 2026 U.S. market submission on track to challenge a $7B industry.

Top policymakers, including Dr. Agustín Carstens and FATF President Luis Urrutia Corral, will convene in Mérida to address critical cross-border tax issues.

As Liberty Latin America preps its 2025 results, investors watch to see if strong subscriber growth and cost-cutting can sustain momentum in a competitive market.

After a major trial failure tanked its stock, Rezolute pins its hopes on a second drug program and a crucial FDA meeting to chart a path forward.

A new report shows the carbon removal market has the tools to fight climate change, but widespread corporate inaction threatens to strand vital projects.

With 100+ new locations in 2025, Smile Doctors' rapid expansion signals a major shift. What does this mean for independent doctors and patient care?

A new strategic alliance aims to bring complex peptide therapies to Europe and India, signaling a shift in global biopharma partnerships and patient access.

Cantor Fitzgerald launches its 15th SPAC, raising $115M. With the market rebounding, will this bet on tech and healthcare pay off for investors?

With a new focus on eye disease and fresh funding, Surrozen will present its novel Wnt-based pipeline to investors. What's at stake for the future of sight?

Empyrean Medical Systems partners with Wide Code to bring its advanced MOVHEET radiation therapy to Greater China, a strategic move in a booming oncology market.

With crucial data on its novel oral inflammation inhibitor looming, NodThera brings in seasoned leader Geoff McDonough to navigate the path to Phase 3.

New 4-year real-world data shows Zevra's drug stabilizes the rare, fatal 'Childhood Alzheimer's' disease, marking a milestone for patients and families.

The entrepreneur is expanding his Mileo Hotels brand to Dominica and launching a new website, signaling a push into sustainable tourism and transparency.